Neudle.com: dilantin toxicity

Differential
(Click to cross reference)

abducens nerve paralysis

abortion, spontaneous

acetazolamide

acquired immunodeficiency syndrome dementia complex

acute cerebellar ataxia

acute intermittant porphyria

advances in neurology

adverse drug reaction

anemia, megaloblastic

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticonvulsants

anticonvulsants, absorption

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, brand name

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, generic

anticonvulsants, hypersensitivity syndrome

anticonvulsants, loading dose

anticonvulsants, mechanism of action of

anticonvulsants, metabolism

anticonvulsants, parenteral administration

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

atrioventricular block

Bassen-Kornzweig syndrome

bee sting

bee sting, neurologic complications with

behavioral disorder

benign essential tremor

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

bone density

bone loss

bone marrow transplantation

burst suppression pattern, electroencephalogram

busulfan

caffeine

calcium antagonist

calcium antagonist, side effects of

carbamazepine, toxicity

central nervous system, infection of

cerebellar ataxia, children

cerebellar ataxia, children, differential diagnosis of

cerebellar atrophy, secondary

cerebellar degeneration

cerebrospinal fluid, elevated protein of

chemotherapy, CNS treatment and complications with

color vision, impaired

congenital birth defects

congenital deformities

congenital heart disease

congenital heart disease, CNS complications with

congenital malformation

congenital malformation, dilantin therapy causing

congenital malformation, non CNS

contrast agents, neurotoxicity of

corpus callosum

corpus callosum, lesion of

creatine phosphokinase(CPK)elevated

developmental evaluation

developmental retardation

diabetes insipidus

digits, abnormal

dilantin

dilantin, factors influencing metabolism of

dilantin, hypersensitivity to

dilantin, intravenous

dilantin, saliva level

dilantin, serum level

dilantin, toxicity

diltiazem

diplopia

disseminated intravascular coagulation(DIC)

drug induced neurologic disorders

drug induced neurologic disorders in children

dyskinesia, buccal lingual facial

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

embryogenesis

emergencies, neurologic

encephalitis

encephalitis, human immunodeficiency virus type 1

epidemiology of neurology

epilepsy

epilepsy referral centers

eye movement, disorders of

fetal valproate syndrome

fetus

fever

fingernails, abnormal

fingernails, hypoplastic

folic acid antagonists

folic acid deficiency

fosphenytoin

gabapentin

gamma amino butyric acid

gender

generic drugs

genetic counselling

genetic neurologic disorders

hallucination, visual

heavy metal intoxication

hemihyperesthesia

hemiparesis

hemisensory loss

hemorrhagic diathesis

hepatic failure

hepatitis

heralding manifestation

human immunodeficiency virus type 1

hyperactivity

hyperammonemic encephalopathy

hypersensitivity reaction

hypogammaglobulinemia

hypoglycemia

hypospadias

hypotension, systemic

hypoxia

iatrogenic neurologic disorders

intelligence quotient

intelligence testing in children

level of consciousness, decreased

liver function enzymes

lorazepam

lordosis

lymphadenopathy

malformation, CNS, congenital

malignant hyperpyrexia

manic-depressive

marihuana

memory, impairment of

meningitis

menses, seizure with

mental retardation

mental status, abnormal

mexiletine

microcephaly

midline defect in children

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

MRI, disappearing lesion on

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

myotonia, treatment of

neuromuscular blockade

neuromuscular junction, abnormality of

neuropathy

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, peripheral

nystagmus, periodic alternating

nystagmus, primary position of gaze

obstetric neurologic injuries

ocular motility, disorders of

oculocephalic reflex

oculovestibular reflex

old age, neurology of

ophthalmoplegia

ophthalmoplegia, total

optic neuritis

optokinetic nystagmus(O.K.N.)

oral contraceptives

oral contraceptives, neurologic complications with

pain, management of chronic

paraldehyde

paramethadione

paroxetine

patient information and support

penicillamine

penicillin

percussion induced muscle contraction

periarteritis nodosa

personality disorder

phantom limb

phencyclidine poisoning

poison, neurologic problems with

polydactyly

polymyositis

polypharmacy

postoperative neurologic complications

practice guidelines

pregabalin

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

prenatal

prenatal diagnosis by amniocentesis

prevention of neurologic disorders

psychiatric problems in neurologic disorders

psychological testing

psychological testing, children

psychomotor retardation

psychosis

ptosis

pulmonary edema

pulmonary function tests

pulmonary infiltrates

pupil, dilated, bilateral

Purkinje cell

purple glove syndrome

respiratory depression

respiratory failure

respiratory paralysis, pharmacologic

review article

rhabdomyolysis

rheumatoid arthritis, neurologic complications of

seizure, breakthrough

seizure, children

seizure, classification of

seizure, complications following

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, maternal

seizure, minor motor

seizure, non-treatment of

seizure, paradoxical

seizure, petit mal

seizure, post traumatic

seizure, pregnancy

seizure, prevention of

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, recurrent

seizure, surgical treatment of

seizure, tonic-clonic

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment of, polytherapy

seizure, withdrawal

seizure, women

seizure, workup of

selective serotonin reuptake inhibitors

sertraline

serum glutamic oxaloacetic transaminase

serum sickness

sexual dysfunction in neurologic disease

skin, lesions in neurologic disorders

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

sore throat

spina bifida

splenium of corpus callosum

statin therapy

status epilepticus

steroid

Stevens-Johnson syndrome

stillbirth

subarachnoid hemorrhage

sympathomimetic drugs

systemic lupus erythematosus, drug induced

temporal lobe, status

toxic epidermal necrolysis

toxins, nervous system

trauma

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, classification

tremor, differential diagnosis of

tremor, intention

tremor, rubral

trigeminal neuralgia

trigeminal neuralgia, treatment of

trimethadione

trimethoprim-sulfamethoxazole

ultrasonography

ultrasonography, head, fetus-neonate

vitamin supplementation

Showing articles 2800 to 2850 of 5240 << Previous Next >>

Outcome of Angioplasty for Atherosclerotic Intracranial Stenosis
Stroke 30:1065-1069, Marks,M.P.,et al, 1999

Prevention of Shoulder Subluxation After Stroke with Electrical Stimulation
Stroke 30:963-968, Linn,S.L.,et al, 1999

Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999

Agranulocytosis Associated with Lamotrigine
BMJ 318:1179, DeCamargo,O.A.K., 1999

Lamotrigine-Induced Tourettism
Neurol 52:1191-1194, Lombroso,C.T., 1999

Toxic Erythroderma Due to Ticlopidine
NEJM 340:1212, Hsi,D.H.,et al, 1999

Assessment:Neurologic Risk of Immunization, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1546-1552, Fenichel,G.M., 1999

Prospective Study of New-Onset Seizures in Patients with Human Immunodeficiency Virus Infection
Arch Neurol 56:609-612, Pascual-Sedano,B.,et al, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine Use,A Report of 3 Cases and Review of the Literature
Arch Int Med 159:311-314, Chen,D.K.,et al,, 1999

Improving the Appropriateness of Carotid Endarterectomy,Results of a Prospective City-Wide Study
Stroke 30:12-15, Wong,J.H.,et al, 1999

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Superficial Siderosis of the Central Nervous System,A Late Complication of Cerebellar Tumors
Neurol 52:163-169, Anderson,N.E.,et al, 1999

Severe Anaphylaxis with Recombinant Interferon Beta
Neurol 52:425, Corona,T.,et al, 1999

Clinicopath Conf,Hepatitis C,Type II Cryoglobulinemia,Vasculitis,B-cell Lymphoma,Mononeuritis Multiplex,Case 3-1999
NEJM 340:300-307, , 1999

Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics 103:158-160, Watemberg,N.M.,et al, 1999

Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999

Medical Complications in Long-Term Survivors with X-Linked Myotubular Myopathy
J Pediatr 134:206-214, Herman,G.E.,et al,, 1999

Riluzole-Induced Pancreatitis
Neurol 52:892-893, Drory,V.E.,et al, 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Brain Tumors in Children
Arch Neurol 56:421-425, Packer,R.J., 1999

Current Treatment of Oligodendrogliomas
Arch Neurol 56:434-436, Perry,J.R.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Dietary Management of Hepatic Encephalopathy in Cirrhotic Patients:Survey of Current Practice in United Kingdom
BMJ 318:1391, 1364, Soulsby,C.T.&Morgan,M.Y., 1999

Salvage Chemotherapy with Tamoxifen for Recurrent Anaplastic Astrocytomas
Arch Neurol 56:703-708, Chamberlain,M.C.&Kormanik,P.A., 1999

Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999

Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999

Melatonin and Painful Gynecomastia
Neurol 53:435-436, DeBleecker,J.L.,et al, 1999

High Incidence of Secondary Brain Tumours after Radiotherapy and Antimetabolites
Lancet 354:34-39, Relling,M.V.,et al, 1999

Generalised Muscular Weakness after Botulinum Toxin Injections for Dystonia:A Report of Three Cases
JNNP 67:90-93, Bhatia,K.P.,et al, 1999

Exacerbating Cervical Spine Injury by Applying a Hard Collar
BMJ 319:171-172, Papadopoulos,M.C.,et al, 1999

Reye's Syndrome in the United States from 1981 Through 1997
NEJM 340:1377-1382,1423, Belay,E.D.,et al, 1999

Rupture of Cerebral Aneurysm During Angiography
NEJM 340:1442, Gailloud,P.&Murphy,K.J., 1999

Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999

Contrast Agent Neurotoxicity Presenting as Subarachnoid Hemorrhage
Neurol 52:1503-1505, Sharp,S.,et al, 1999

Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999

Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999

Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999

Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Ventricular Asystole During Vagus Nerve Stimulation for Epilepsy in Humans
Neurol 52:1267-1269,1117, Tatum,IV,W.O.,et al, 1999

A Randomized, Placebo-Controlled Study of Topiramate in Primary Generalized Tonic-Clonic Seizures
Neurol 52:1330-1337, Biton,V.,et al, 1999

Drug Points, Transient Hemiparesis with Topiramate
BMJ 318:845, Stephen,L.J.,et al, 1999

Showing articles 2800 to 2850 of 5240 << Previous Next >>